St. Louis, MO, May 05, 2021 (GLOBE NEWSWIRE) RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network (NCCN) Clinical
RadioMedix & Curium Announce DetectnetTM (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
Share Article
RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology – Neuroendocrine and Adrenal Tumors, version 1.2021 for the evaluation of neuroendocrine tumors (NETs). ST. LOUIS, Mo. (PRWEB) May 05, 2021 RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology – Neuroendocrine and Adrenal Tumors, version 1.2021 for the evaluation of neuroendocrine tumors (NETs). Detectnet is a positron emission tomography (PET) agent indicated for the localization of somatostatin receptor positive neuroendocrine tumors in adults.
(0)
St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the U.S. Food and Drug Administration (FDA). Curium has been granted priority review by the FDA, which has set a Generic Drug User Fee Act (GDUFA) goal date in Q4 2021. Ioflupane I 123 Injection is a single-photon emission computed tomography (SPECT) brain imaging agent used to assist in the evaluation of adult patients with suspected Parkinsonian syndromes. Curium is committed to developing generic medications for clinicians and patients at a lower cost, said Michael Patterson, Curium s North American V.P. of Marketing. Our weekend manufacturing across our portfolio and logistical capabilities also afford the market the opportunity to scan patients starting in the beginning of the week and early in the morning.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Curium to Expand Noblesville Facility’s Workforce
CuriumApril 28, 2021 GMT
St. Louis, MO, April 28, 2021 (GLOBE NEWSWIRE) Curium, the world’s largest nuclear medicine company, has announced plans to invest in new jobs at its Noblesville location – furthering its commitment and impact in the medical technology and life science innovation industry.
Curium announced the addition of 34 high-paying jobs in the next three years within its existing building in Noblesville at 14395 Bergen Blvd. in the Saxony Corporate Campus.
“We are excited to expand our footprint and capabilities at our Noblesville facility to provide our customers and patients reliable access to our innovative products,” Roy Brown, Curium VP of Government Affairs said. “We appreciate the collaboration and support of the city as we move forward.”
Premium Content
Subscriber only
BELOVED Gympie larrikin, mum, grandma and midwife Melissa Orrman loves nothing more than a good laugh and a big adventure.
Whatever event you are at in Gympie, chances are you will be able to spot Melissa - she’s usually the one laughing loudly and wearing something eye catching but stylish.
Shy she is not. Colourful, fun and daring she most definitely is.
Happily single - or so we thought - she has travelled the world on her own, and in 2015 famously won $50,000 on Eddie McGuire’s Hot Seat Millionaire, cheekily sitting on Eddie’s knee and shamelessly bragging about it ever since.